KraneShares MSCI All China Health Care Index ETF
$18.09−0.39 (−2.11%)
- 0.79%
- $113M
- −1.7%
- 3.88%
- 0.1M sh
- $18.56
- low $14.38high $19.93
The ETF.net KURE Grade
F
Score 20 out of 100
- 23 of 25
Score 20 of 100 falls in the F band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.
Cost
The fund’s net expense ratio, ranked against its category.F10 out of 100Rank 22 of 25Mission
Whether the fund did what it promised, tested against its stated mandate.Risk
How the fund held up when markets fell: downside volatility, drawdowns and tail loss.F10 out of 100Rank 23 of 24Tradability
How easy the fund is to trade: daily volume, and how far its price strays from net asset value.F24 out of 100Rank 22 of 25Holdings
How concentrated the fund is, and how complete and current its disclosed holdings are.C52 out of 100Rank 16 of 25Durability
Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.D37 out of 100Rank 18 of 25
Our read on KURE
FNearly every health care ETF on the shelf is a US pharma-and-devices basket. KURE points the other way: about 50 Chinese healthcare names, tracked through an MSCI China index, in one ticker.
KURE is designed to track the MSCI China All Shares Healthcare 10/40 Index, which represents Chinese companies engaged in the healthcare sector.
Why people hold it
- The exposure US sector funds skip. VHT, FHLC and XLV own American health care; KURE follows the MSCI China All Shares Healthcare 10/40 Index instead.
- Rules-based and compact: roughly 50 holdings set by a published MSCI index, not by a manager's conviction call.
- Trading since 2018 with moderate volume behind it, so this is a seasoned fund rather than a thin new launch chasing a theme.
Worth knowing
- 0.79% a year is specialist pricing. The big US health care index funds on the same shelf charge 0.08% (XLV, FHLC).
- One country, one sector. Chinese regulation, currency and market-access rules drive this fund in ways a US pharma basket never feels.
- A smaller fund than the sector giants, so spreads can run wider. Cash comes back once or twice a year, not monthly.
KURE Holdings
- Stocks
- 44
- 56%
- 6160.HK
Sectors
- Health Care99.1%
- Consumer Staples0.9%
Geography
- China83.31%
- Switzerland8.73%
- Hong Kong7.18%
- United States0.77%
Developed 16% · Emerging 84%
KURE Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
Not enough history yet.
KURE$9,832
Returns run to the Oct 12, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | KURE |
|---|---|
| Year to date | +8.0% |
| 1 month | +3.8% |
| 3 months | +8.4% |
| 1 year | −1.7% |
| 3 years | +2.8% |
| 5 years | −9.1% |
| 10 years | — |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | KURE |
|---|---|---|
| 2026 YTD | +8.0% | |
| 2025 | +24.9% | |
| 2024 | −17.8% | |
| 2023 | −17.7% | |
| 2022 | −25.4% | |
| 2021 | −15.8% | |
| 2020 | +69.0% |
KURE in the news
KURE Dividends
- 3.88%
- $0.71
- $0.71 per share
- Annual
Distribution history
KURE Risk
- 26.0%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 0.13
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −59.3%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 0.41
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
KURE Cost
0.79%
KURE0.79%
- The middle half of Health Care (Broad) funds
- Median 0.50%
21 of the 25 Health Care (Broad) funds charge less.
Other funds in Health Care (Broad)
- DEKGFirst Trust Nasdaq Lux Digital Health Solutions ETFExpense ratio 0.65%1 year return +35.4%
- DMDEVFirst Trust Indxx Medical Devices ETFExpense ratio 0.70%1 year return +5.9%
- DGDOCGoldman Sachs Future Health Care Equity ETFExpense ratio 0.75%1 year return +11.4%
- DHRTSTema Heart & Health ETFExpense ratio 0.99%1 year return +14.5%
- FLGHTLangar Global HealthTech ETFExpense ratio 0.85%1 year return +9.0%